Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Shares of Organon & Co (NYSE:OGN) rose sharply in pre-market trading as the company agreed to be acquired by Sun Pharma in an $11.75 billion deal.

Sun Pharma will acquire all outstanding shares of Organon for $14.00 per share.

Organon shares jumped 14.8% to $12.93 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Onconetix Inc (NASDAQ:ONCO) gained 46.4% to $0.86 in pre-market trading after the company announced the resignation of Andrew Oakley as chairman of board.
• DarkIris Inc (NASDAQ:DKI) gained 34.1% to $0.62 in pre-market trading. The company announced closing of a $3.8 million PIPE financing and $800,000 content asset acquisition.
• Aditxt Inc (NASDAQ:ADTX) rose 30.8% to $0.37 in pre-market trading after falling over 2% on Friday.
• Intellia Therapeutics Inc (NASDAQ:NTLA) rose 25.6% to $17.12 in pre-market trading after the company announced it will report topline clinical data from its global Phase 3 HAELO trial of lonvoguran ziclumeran in hereditary angioedema on April 27.
• SMX (Security Matters) PLC (NASDAQ:SMX) gained 17.9% to $2.45 in pre-market trading after dipping over 40% on Friday.
• Atomera Inc (NASDAQ:ATOM) rose 15.3% to $9.92 in pre-market trading. Atomera shares jumped 39% on Friday after the company announced an expanded collaboration with Synopsys to advance gallium nitride device modeling for radio frequency and power semiconductor applications.
• Maison Solutions Inc (NASDAQ:MSS) gained 14.5% to $1.34 in pre-market trading after rising 4% on Friday.
• POET Technologies Inc (NASDAQ:POET) jumped 10.7% to $16.72 in pre-market trading after surging more than 28% on Friday.
• Compass Therapeutics Inc. (NASDAQ:CMPX) gained 10.5% to $5.55 in pre-market trading. Compass Therapeutics will host webcast on April 27 to review topline secondary endpoints from Phase 2/3 COMPANION-002 clinical study assessing tovecimig in combination with paclitaxel in advanced biliary tract cancer.

Losers

• Chanson International Holding (NASDAQ:CHSN) fell 29.4% to $0.13 in pre-market trading after dipping more than 92% on Friday.
• Cheetah Net Supply Chain Service Inc (NASDAQ:CTNT) declined 22.5% to $0.033 in pre-market trading after the company disclosed a 1-for-200 reverse stock split.
• Nuvve Holding Corp (NASDAQ:NVVE) tumbled 20.1% to $0.40 in pre-market trading after gaining 3% on Friday.
• Q32 Bio Inc (NASDAQ:QTTB) shares dipped 19.6% to $5.00 in pre-market trading. Q32 Bio filed prospectus to launch a new $75 million at-the-market offering program.
• Scinai Immunotherapeutics Ltd – ADR (NASDAQ:SCNI) fell 13.8% to $0.64 in pre-market trading. Scinai Immunotherapeutics shares jumped 62% on Friday after the company announced a $2.61 million private placement financing.
• Medicus Pharma Ltd (NASDAQ:MDCX) fell 13.3% to $0.27 in pre-market trading after declining 5% on Friday.
• Fitell Corp (NASDAQ:GMEX) dipped 12.1% to $0.41 in pre-market trading after gaining 25% on Friday.
• Nuburu Inc (NYSE:BURU) fell 11.2% to $0.28 in pre-market trading. Nuburu filed prospectus for resale of up to 60 million shares of common stock by YA II PN, LTD.
• Orion Group Holdings Inc (NYSE:ORN) fell 7.9% to $11.30 in pre-market trading.
• MMTec Inc (NASDAQ:MTC) dipped 6.7% to $6.26 in pre-market trading after gaining 3% on Friday.

Photo via Shutterstock